Contezolid is an oxazolidinone antimicrobial agent newly approved for treatment of multidrug-resistant (MDR) Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
oxazolidinone antibioticARO:3000079
ARO:3000079| Molecular formula | C18H15F3N4O4 |
|---|---|
| Charge | 0 |
| Average mass | 408.3 Da |
| Monoisotopic mass | 408.10453946 Da |
| Source | PubChem · retrieved 2026-08-29 |
| InChIKey | SULYVXZZUMRQAX-NSHDSACASA-N |
C1CN(C=CC1=O)C2=C(C=C(C(=C2F)F)N3C[C@@H](OC3=O)CNC4=NOC=C4)F
InChI=1S/C18H15F3N4O4/c19-12-7-13(15(20)16(21)17(12)24-4-1-10(26)2-5-24)25-9-11(29-18(25)27)8-22-14-3-6-28-23-14/h1,3-4,6-7,11H,2,5,8-9H2,(H,22,23)/t11-/m0/s1
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3007474 |
contezolid | antibioticmech:aro-ca0e85f42a |
2026-08-30 |
Seeded from data/raw/ inventories (ARO)
Re-seeded from updated data/raw/ inventories
Re-seeded from updated data/raw/ inventories